Advertisement

Topics

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Avalanche Biotechnologies, Inc. and a Lead Plaintiff Deadline of September 8, 2015 - AAVL

20:00 EDT 11 Aug 2015 | Globe Newswire

NEW YORK, Aug. 12, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) securities pursuant and/or traceable to the Company's Initial Public Offering on or about July 31, 2014 and/or between July 31, 2014 and June 15, 2015.

Click here to learn about the case: http://docs.wongesq.com/AAVL-Info-Request-Form-847. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements and/or failed to disclose that Phase 2a of the study for its drug AVA-101 was not designed to show any statistical significance between the active and control groups in the secondary endpoints.

If you suffered a loss in Avalanche you have until September 8, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/AAVL-Info-Request-Form-847.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Vincent Wong, Esq.
         39 East Broadway
         Suite 304
         New York, NY 10002
         Tel. 212.425.1140
         Fax. 866.699.3880
         E-Mail: vw@wongesq.com
NEXT ARTICLE

More From BioPortfolio on "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Avalanche Biotechnologies, Inc. and a Lead Plaintiff Deadline of September 8, 2015 - AAVL"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...